BMC Public Health:大叔,干杯前请三思啊

2018-09-18 BMC中国 BMC期刊

最近发表在BMC Public Health上的研究表明,对于酒精摄入量较低的中年饮酒者(30-65岁),喝酒时很少甚至不会顾虑饮酒对健康的影响。

最近发表在BMC Public Health上的研究表明,对于酒精摄入量较低的中年饮酒者(30-65岁),喝酒时很少甚至不会顾虑饮酒对健康的影响。

来自澳大利亚阿德莱德大学的研究者们对13个研究进行了分析,发现没有酗酒问题的中年饮酒者,其饮酒行为会受到得体程度、性别和是否有他人在场等因素的影响,但对健康问题的担忧不在影响因素之列。

研究的通讯作者Emma Muhlack说:“健康居然不是中年人饮酒时的重点考虑因素,这一点很让人惊讶。他们即便考虑健康时,也通常会以自己的经验作为参考标准(比如自己喝太多时会有什么感觉),而不是参照健康组织制定的指南。”

作者发现,中年饮酒者认为以符合其年龄或生活阶段的方式饮酒很重要,这样才能让他们履行自己的责任,避免出现明显的醉酒迹象。性别也会影响对饮酒行为是否可接受的判断,某些饮品被认为更适合女性,其他一些则更适合男性。另外,在家中饮酒与女性相关性较高,在公共场合饮酒则与男性相关性较高。

Emma Muhlack说:“我们对中年饮酒者饮酒的决策过程知之甚少。这个综述的结果有助于我们更好地了解饮酒是如何融入中年人的日常生活,以及在尝试减少中年人饮酒量时应该考虑哪些因素。”

这些研究结果表明,旨在减少中年中度饮酒者饮酒量的公共卫生运动,如果将关注点放在饮酒者可能因做出不合宜的饮酒行为而承担的风险——比如没有履行自己对他人应尽的职责,可能对他人造成伤害,以及可能会失去别人的尊敬——而非个人的健康后果,可能会更加有效。

作者对13篇论文进行了分析,其中包括9篇来自英国的文章,这些论文研究了酒精摄入量以及包括中年中度饮酒者在内的饮酒人群的体验。

作者提醒,由于这篇综述中所分析的研究大部分是在英国进行的,所以对于其他国家而言结果的普适性可能有限。

原始出处:
Emma Muhlack, Drew Carter, Annette Braunack-Mayer, et al. Constructions of alcohol consumption by non-problematised middle-aged drinkers: a qualitative systematic review. BMC Public Health. 18 September 2018. 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1974856, encodeId=a6b119e48566b, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Nov 11 09:05:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861258, encodeId=e0721861258f6, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Jul 17 19:05:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621751, encodeId=155f1621e515d, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Sep 20 13:05:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345571, encodeId=6a2b3455e1d2, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Sep 18 22:49:29 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1974856, encodeId=a6b119e48566b, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Nov 11 09:05:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861258, encodeId=e0721861258f6, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Jul 17 19:05:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621751, encodeId=155f1621e515d, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Sep 20 13:05:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345571, encodeId=6a2b3455e1d2, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Sep 18 22:49:29 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
    2019-07-17 shizhenshan
  3. [GetPortalCommentsPageByObjectIdResponse(id=1974856, encodeId=a6b119e48566b, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Nov 11 09:05:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861258, encodeId=e0721861258f6, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Jul 17 19:05:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621751, encodeId=155f1621e515d, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Sep 20 13:05:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345571, encodeId=6a2b3455e1d2, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Sep 18 22:49:29 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1974856, encodeId=a6b119e48566b, content=<a href='/topic/show?id=f145355379' target=_blank style='color:#2F92EE;'>#BMC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3553, encryptionId=f145355379, topicName=BMC)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdqq.qlogo.cn/qqapp/101173734/363C99735735B7F4CB11D5F78F580525/100, createdBy=aab22500211, createdName=ms3025846204744509, createdTime=Sun Nov 11 09:05:00 CST 2018, time=2018-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861258, encodeId=e0721861258f6, content=<a href='/topic/show?id=401a23e102' target=_blank style='color:#2F92EE;'>#ALT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2371, encryptionId=401a23e102, topicName=ALT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ccbd84, createdName=shizhenshan, createdTime=Wed Jul 17 19:05:00 CST 2019, time=2019-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1621751, encodeId=155f1621e515d, content=<a href='/topic/show?id=5f1386329e' target=_blank style='color:#2F92EE;'>#Health#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8632, encryptionId=5f1386329e, topicName=Health)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8d2020283215, createdName=yyanpro@28cn.c, createdTime=Thu Sep 20 13:05:00 CST 2018, time=2018-09-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=345571, encodeId=6a2b3455e1d2, content=了解一下,谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Tue Sep 18 22:49:29 CST 2018, time=2018-09-18, status=1, ipAttribution=)]
    2018-09-18 天地飞扬

    了解一下,谢谢分享!

    0

相关资讯

Cardiovasc Res:适量饮酒保护心脏的作用与乙醛脱氢酶2有关

2018年6月发表于《Cardiovascular Research》杂志上的一项研究表明,适量饮酒保护心脏的作用可能与乙醛脱氢酶2(ALDH2)的激活有关。

J Thromb Haemost:饮酒与肺栓塞风险有关吗?

由此可见,在三个美国男性和女性的大型前瞻性队列中,研究人员并未发现饮酒量和频率与PE风险之间存在关联的证据。

一文看懂:癌症与吸烟、饮酒、超重、紫外线的相关度

发表在美国癌症研究所(AICR)的一项研究表明,癌症患者死亡45%可归因于和可控危险因素,包括吸烟、超重、饮酒、摄入牛羊肉和加工肉类、水果蔬菜和膳食钙摄入量低、活动过少、紫外线辐射暴露、特定感染。这些因素并非遗传而来,而是可以通过自身控制调节的。也就是说,如果控制得当,就能降低癌症发生的风险!

Eur Heart J:吸烟与饮酒,如果发生在17岁那年的雨季...

一项新研究发现,有吸烟和饮酒习惯的青少年在17岁时,动脉已经比不吸烟的同龄人要更加僵硬。

Eur J Gastroenterol Hepatol:在原发性胆汁性胆管炎患者中,吸烟与晚期肝纤维化相关

在PBC患者中,吸烟,无论是主动还是被动均与晚期纤维化有关。在患有晚期肝纤维化的吸烟者中,死亡率升高。

J Neurol Neurosur Ps:饮酒与肌萎缩侧索硬化风险之间的关系

由此可见,除少数例外,饮酒与ALS之间未发现显著相关性。对酒精与ALS之间关联的研究需要进行彻底地探索,特别是考虑到不同类型酒精饮料的作用时。